Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
Saved in:
Main Author: | Rohini Handa |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Indian Journal of Rheumatology |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=3;spage=212;epage=213;aulast=Handa |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective cohort study in Japan
by: Genri Tagami, et al.
Published: (2025-01-01) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
by: Saket Jha, et al.
Published: (2019-01-01) -
Clinical Images: Propylthiouracil‐induced antineutrophil cytoplasmic antibody–associated vasculitis with aortic wall thickening
by: Sho Ishigaki, et al.
Published: (2025-01-01) -
Inflammatory Bowel Disease in Indo-Canadians with and without Antineutrophil Cytoplasmic Autoantibodies
by: Hugh James Freeman
Published: (2000-01-01) -
Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
by: Ulrich Specks, et al.
Published: (2025-01-01)